NCT00258362View on ClinicalTrials.gov

Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Endometrial Cancer
Interventions
DRUG

carboplatin

Dose = Area-under-the-curve 6 on Day 1 every 3 weeks for 3 cycles.

DRUG

docetaxel

75 mg/m\^2 on Day 1 of each course

RADIATION

radiation therapy

Weekly, 5 days/week over 6-7 weeks (tailored 4500 cGy)

Trial Locations (2)

55426

Park Nicollet Cancer Center, Saint Louis Park

55455

Masonic Cancer Center, University of Minnesota, Minneapolis

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Masonic Cancer Center, University of Minnesota

OTHER